TAGLN2 and metastatic neoplasm: These data demonstrate that advanced ovarian tumors limit the protective capacity of adoptively transferred CER T cells by abrogating TAGLN2, and that preserving the expression of this cytoskeletal factor enables CER T cells to bypass the detrimental effects of tumor-induced ER stress, conferring improved therapeutic effects against metastatic disease.